{"taxa": [{"scientific_name": "euclea pseudebenus", "compounds": ["mamegakinone", "2-methylnaphthazarin", "euclein"], "accepted_name": "Euclea pseudebenus", "accepted_species": "Euclea pseudebenus", "accepted_genus": "Euclea", "inchi_keys": {"mamegakinone": "FMQQGWMGTKBWHR-UHFFFAOYSA-N", "2-methylnaphthazarin": "YKPXIWHBRBFRQM-UHFFFAOYSA-N", "euclein": "WRFTYMHHWSAKSK-UHFFFAOYSA-N"}, "inchi_key_simps": {"mamegakinone": "FMQQGWMGTKBWHR", "2-methylnaphthazarin": "YKPXIWHBRBFRQM", "euclein": "WRFTYMHHWSAKSK"}}, {"scientific_name": "euclea undulata", "compounds": ["diospyrin", "epicatechin", "lupeol", "7-methyl-juglone", "isodiospyrin", "\u03b1-amyrin-3o-\u00df-(5-hydroxy) ferulic acid"], "accepted_name": "Euclea undulata", "accepted_species": "Euclea undulata", "accepted_genus": "Euclea", "inchi_keys": {"diospyrin": "WRFTYMHHWSAKSK-UHFFFAOYSA-N", "epicatechin": "PFTAWBLQPZVEMU-UKRRQHHQSA-N", "lupeol": "MQYXUWHLBZFQQO-QGTGJCAVSA-N", "7-methyl-juglone": "OZUSCVSONBBWOR-UHFFFAOYSA-N", "isodiospyrin": "OEEOHKZVBKYMBA-UHFFFAOYSA-N"}, "inchi_key_simps": {"diospyrin": "WRFTYMHHWSAKSK", "epicatechin": "PFTAWBLQPZVEMU", "lupeol": "MQYXUWHLBZFQQO", "7-methyl-juglone": "OZUSCVSONBBWOR", "isodiospyrin": "OEEOHKZVBKYMBA"}}, {"scientific_name": "euclea natalensis", "compounds": ["mamegakinone", "octahydroeuclein", "shinanolone", "diospyrin", "neodiospyrin", "lupeol", "betulin", "isodiospyrin", "\u03b2-sitosterol", "20 (29)-lupene-3\u03b2-isoferulate", "20 (29)-lupene-3\u03b1-isoferulate", "7-methyl-juglone"], "accepted_name": "Euclea natalensis", "accepted_species": "Euclea natalensis", "accepted_genus": "Euclea", "inchi_keys": {"mamegakinone": "FMQQGWMGTKBWHR-UHFFFAOYSA-N", "octahydroeuclein": "XXBQCKGZTFHKKF-FBVQZCABSA-N", "shinanolone": "JOCZVRFSKAUXRP-MRVPVSSYSA-N", "diospyrin": "WRFTYMHHWSAKSK-UHFFFAOYSA-N", "neodiospyrin": "LZAXNDGRDVWTFX-UHFFFAOYSA-N", "lupeol": "MQYXUWHLBZFQQO-QGTGJCAVSA-N", "betulin": "FVWJYYTZTCVBKE-ROUWMTJPSA-N", "isodiospyrin": "OEEOHKZVBKYMBA-UHFFFAOYSA-N", "\u03b2-sitosterol": "KZJWDPNRJALLNS-VJSFXXLFSA-N", "7-methyl-juglone": "OZUSCVSONBBWOR-UHFFFAOYSA-N"}, "inchi_key_simps": {"mamegakinone": "FMQQGWMGTKBWHR", "octahydroeuclein": "XXBQCKGZTFHKKF", "shinanolone": "JOCZVRFSKAUXRP", "diospyrin": "WRFTYMHHWSAKSK", "neodiospyrin": "LZAXNDGRDVWTFX", "lupeol": "MQYXUWHLBZFQQO", "betulin": "FVWJYYTZTCVBKE", "isodiospyrin": "OEEOHKZVBKYMBA", "\u03b2-sitosterol": "KZJWDPNRJALLNS", "7-methyl-juglone": "OZUSCVSONBBWOR"}}, {"scientific_name": "euclea divinorum", "compounds": ["quercetin-3-o-\u03b1-l-rhamnopyranoside", "mamegakinone", "aromadendrin-3-o-\u03b2-l-arabinopyranoside", "diospyrin", "eucleanal", "lupene", "\u03b3-sitosterol", "germanicol", "lupeol", "betulin", "eucleanal a", "catechin", "myricetin-3-o-\u03b1-l-rhamnopyranoside", "7-methyl-juglone", "eucleanal b"], "accepted_name": "Euclea divinorum", "accepted_species": "Euclea divinorum", "accepted_genus": "Euclea", "inchi_keys": {"quercetin-3-o-\u03b1-l-rhamnopyranoside": "OXGUCUVFOIWWQJ-OQCXDQQJSA-N", "mamegakinone": "FMQQGWMGTKBWHR-UHFFFAOYSA-N", "diospyrin": "WRFTYMHHWSAKSK-UHFFFAOYSA-N", "\u03b3-sitosterol": "KZJWDPNRJALLNS-FBZNIEFRSA-N", "germanicol": "QMUXVPRGNJLGRT-PNTWTTAKSA-N", "lupeol": "MQYXUWHLBZFQQO-QGTGJCAVSA-N", "betulin": "FVWJYYTZTCVBKE-ROUWMTJPSA-N", "catechin": "PFTAWBLQPZVEMU-DZGCQCFKSA-N", "7-methyl-juglone": "OZUSCVSONBBWOR-UHFFFAOYSA-N"}, "inchi_key_simps": {"quercetin-3-o-\u03b1-l-rhamnopyranoside": "OXGUCUVFOIWWQJ", "mamegakinone": "FMQQGWMGTKBWHR", "diospyrin": "WRFTYMHHWSAKSK", "\u03b3-sitosterol": "KZJWDPNRJALLNS", "germanicol": "QMUXVPRGNJLGRT", "lupeol": "MQYXUWHLBZFQQO", "betulin": "FVWJYYTZTCVBKE", "catechin": "PFTAWBLQPZVEMU", "7-methyl-juglone": "OZUSCVSONBBWOR"}}, {"scientific_name": "euclea lanceolata", "compounds": ["8,8\u2019-dihydroxy-4,4\u2019-dimethoxy-6,6\u2019-dimethyl-2,2\u2019-binaphthyl-l,l\u2019-quinone", "mamegakinone", "8\u2019-hydroxydiospyrin"], "accepted_name": "Euclea crispa subsp. crispa", "accepted_species": "Euclea crispa", "accepted_genus": "Euclea", "inchi_keys": {"mamegakinone": "FMQQGWMGTKBWHR-UHFFFAOYSA-N"}, "inchi_key_simps": {"mamegakinone": "FMQQGWMGTKBWHR"}}, {"scientific_name": "euclea crispa var crispa", "compounds": ["diospyrin"], "accepted_name": "Euclea crispa subsp. crispa", "accepted_species": "Euclea crispa", "accepted_genus": "Euclea", "inchi_keys": {"diospyrin": "WRFTYMHHWSAKSK-UHFFFAOYSA-N"}, "inchi_key_simps": {"diospyrin": "WRFTYMHHWSAKSK"}}, {"scientific_name": "euclea crispa subsp. crispa", "compounds": ["3-oxo-oleanolic acid", "3\u03b2-(5-hydroxyferuloyl)lup-20(30)-ene", "betulin", "natalonone"], "accepted_name": "Euclea crispa subsp. crispa", "accepted_species": "Euclea crispa", "accepted_genus": "Euclea", "inchi_keys": {"betulin": "FVWJYYTZTCVBKE-ROUWMTJPSA-N"}, "inchi_key_simps": {"betulin": "FVWJYYTZTCVBKE"}}, {"scientific_name": "euclea racemosa ssp. schimperi", "compounds": ["mamegakinone", "neodiospyrin", "myricetin-3-o-arabinopyranoside", "isodiospyrin", "rutin", "7-methyl-juglone"], "accepted_name": "Euclea racemosa", "accepted_species": "Euclea racemosa", "accepted_genus": "Euclea", "inchi_keys": {"mamegakinone": "FMQQGWMGTKBWHR-UHFFFAOYSA-N", "neodiospyrin": "LZAXNDGRDVWTFX-UHFFFAOYSA-N", "isodiospyrin": "OEEOHKZVBKYMBA-UHFFFAOYSA-N", "rutin": "IKGXIBQEEMLURG-NVPNHPEKSA-N", "7-methyl-juglone": "OZUSCVSONBBWOR-UHFFFAOYSA-N"}, "inchi_key_simps": {"mamegakinone": "FMQQGWMGTKBWHR", "neodiospyrin": "LZAXNDGRDVWTFX", "isodiospyrin": "OEEOHKZVBKYMBA", "rutin": "IKGXIBQEEMLURG", "7-methyl-juglone": "OZUSCVSONBBWOR"}}, {"scientific_name": "euclea kellau", "compounds": ["ursolic acid lactone", "lupeol", "betulin", "ursolic acid", "\u03b1-amyrin", "uvaol"], "accepted_name": "Euclea racemosa subsp. schimperi", "accepted_species": "Euclea racemosa", "accepted_genus": "Euclea", "inchi_keys": {"ursolic acid lactone": "JGZVNQDYYGVIBP-RUOWOPRNSA-N", "lupeol": "MQYXUWHLBZFQQO-QGTGJCAVSA-N", "betulin": "FVWJYYTZTCVBKE-ROUWMTJPSA-N", "ursolic acid": "WCGUUGGRBIKTOS-GPOJBZKASA-N", "\u03b1-amyrin": "FSLPMRQHCOLESF-SFMCKYFRSA-N", "uvaol": "XUARCIYIVXVTAE-ZAPOICBTSA-N"}, "inchi_key_simps": {"ursolic acid lactone": "JGZVNQDYYGVIBP", "lupeol": "MQYXUWHLBZFQQO", "betulin": "FVWJYYTZTCVBKE", "ursolic acid": "WCGUUGGRBIKTOS", "\u03b1-amyrin": "FSLPMRQHCOLESF", "uvaol": "XUARCIYIVXVTAE"}}, {"scientific_name": "euclea latideus", "compounds": ["lupeol", "betulin"], "accepted_name": "Euclea", "accepted_species": null, "accepted_genus": null, "inchi_keys": {"lupeol": "MQYXUWHLBZFQQO-QGTGJCAVSA-N", "betulin": "FVWJYYTZTCVBKE-ROUWMTJPSA-N"}, "inchi_key_simps": {"lupeol": "MQYXUWHLBZFQQO", "betulin": "FVWJYYTZTCVBKE"}}, {"scientific_name": "euclea schimperi", "compounds": ["mamegakinone"], "accepted_name": "Euclea racemosa subsp. schimperi", "accepted_species": "Euclea racemosa", "accepted_genus": "Euclea", "inchi_keys": {"mamegakinone": "FMQQGWMGTKBWHR-UHFFFAOYSA-N"}, "inchi_key_simps": {"mamegakinone": "FMQQGWMGTKBWHR"}}, {"scientific_name": "euclea crispa", "compounds": ["farnesol", "isodiospyrin"], "accepted_name": "Euclea crispa", "accepted_species": "Euclea crispa", "accepted_genus": "Euclea", "inchi_keys": {"farnesol": "CRDAMVZIKSXKFV-YFVJMOTDSA-N", "isodiospyrin": "OEEOHKZVBKYMBA-UHFFFAOYSA-N"}, "inchi_key_simps": {"farnesol": "CRDAMVZIKSXKFV", "isodiospyrin": "OEEOHKZVBKYMBA"}}, {"scientific_name": "euclea racemosa", "compounds": ["rutin", "myricetin-3-o-arabinopyranoside"], "accepted_name": "Euclea racemosa", "accepted_species": "Euclea racemosa", "accepted_genus": "Euclea", "inchi_keys": {"rutin": "IKGXIBQEEMLURG-NVPNHPEKSA-N"}, "inchi_key_simps": {"rutin": "IKGXIBQEEMLURG"}}], "text": "Ethnobotanical uses,phytochemistry and biologicalactivity of the genus Euclea: AreviewAbebe Dagne Taye1, Gizachew Kassahun Bizuneh2* andAsmamaw Emagn Kasahun31Department of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia,2Department of Pharmacognosy, School of Pharmacy, College of Medicine and Health Sciences,University of Gondar, Gondar, Ethiopia, 3Department of Pharmaceutics, School of Pharmacy, College ofMedicine and Health Sciences, University of Gondar, Gondar, EthiopiaEuclea (Ebenaceae) is a genus of flowering shrubs and trees widely distributed inAfrica, the Comoro Islands, and Arabia. This review aimed to evaluate theethnobotanical uses, phytochemistry, and biological activities of the genusEuclea on available research reports. This was achieved through PubMed,Medline, Google Scholar, Science Direct, Taylor and Francis Online, WileyOnline Library which provides access to scientific and medical research. Theextensive literature survey revealed that plants that belong to this genus are usedas folkloric medicine for the treatment of diabetes mellitus, toothache, diarrhea,cancer, malaria, leprosy, and genital and oral diseases in the case of HIV/AIDS-related diseases. To date, more than 40 secondary metabolites have beenisolated and identified from these plants, especially from E natalensis and E.divinorum. Among these, naphthoquinones, terpenes, and flavonoids arepotential secondary metabolites with profound biological activities. Eucleaplant extracts and their bioactive compounds possess outstandingpharmacological properties, especially antimalarial, antidiabetic, anticancer,antimicrobial, and antioxidant properties.KEYWORDSEuclea, naphtoquinones, phytochemistry, ethnobotanical use, pharmacological activityIntroductionThe word \u201cEuclea\u201d comes from a Greek word \u201ceukleia\u201d, \u201ceu\u201d meaning \u201cgood\u201d, and\u201ckleios\u201dmeaning report (Maroyi, 2017). The genus Euclea belongs to the family Ebenaceaeand is composed of 16 accepted species (Dhayalan et al., 2015; Botha, 2016).The genus Euclea is distributed in the tropical and subtropical regions of the world.However, it is most abundant in Eastern and Southern Africa (Mebe et al., 1998) and South-East Asia (Botha, 2016). Euclea divinorum is distributed in Botswana, South Africa, Namibia,Swaziland, Zimbabwe, Tanzania, Uganda (Shumba, 2018), Sudan, Kenya, and Ethiopia(Woldemedhin et al., 2017). Euclea natalensis is widely found along the eastern coast ofsouthern Africa (Johanna, 2007). Euclea latideus is well presented in the lowlands of thetropical and to a lesser extent, in subtropical regions of the world (Philip et al., 2018). Aversatile medicinal plant in Ethiopia from this genus is Euclea divinorum. Traditionally it isused for the treatment of skin inflammation, scabies, cancer, hepatitis, urinary inconsistency,OPEN ACCESSEDITED BYFran\u00e7ois Chassagne,IRD UMR152 Pharmacochimie et BiologiePour le D\u00e9veloppement (PHARMADEV),FranceREVIEWED BYSmith B. Babiaka,University of Buea, CameroonLatifa Bouissane,Universit\u00e9 Sultan Moulay Slimane,Morocco*CORRESPONDENCEGizachew Kassahun Bizuneh,gizachewkassahun4@gmail.comRECEIVED 20 February 2023ACCEPTED 05 April 2023PUBLISHED 19 April 2023CITATIONTaye AD, Bizuneh GK and Kasahun AE(2023), Ethnobotanical uses,phytochemistry and biological activity ofthe genus Euclea: A review.Front. Pharmacol. 14:1170145.doi: 10.3389/fphar.2023.1170145COPYRIGHT\u00a9 2023 Taye, Bizuneh and Kasahun. Thisis an open-access article distributedunder the terms of the CreativeCommons Attribution License (CC BY).The use, distribution or reproduction inother forums is permitted, provided theoriginal author(s) and the copyrightowner(s) are credited and that the originalpublication in this journal is cited, inaccordance with accepted academicpractice. No use, distribution orreproduction is permitted which does notcomply with these terms.Frontiers in Pharmacology frontiersin.org01TYPE ReviewPUBLISHED 19 April 2023DOI 10.3389/fphar.2023.1170145chest pain, pneumonia, gonorrhea, constipation, edema, abdominaland chest pain (Feyissa et al., 2013; Woldemedhin et al., 2017;Mekonnen et al., 2018).Botanical profile and taxonomy of EucleaMost of the plants are trees, shrubs, and sub-shrubs, usuallyevergreen with alternate, opposite to sub-opposite, or in pseudo-whorls and diamond leaved (Figure 1A). Inflorescences: dioecious,axillary, or less frequently in branched pseudo-racemes, or flowersoccasionally solitary (Figure 1B). Calyx: 4-5-lobed, usuallypolysepalous, not accrescent on fruits. Corolla: urceolate tosubglobose, 5 - 8-lobed or campanulate and deeply 4-5-lobed.Stamens: 10-30; anthers dehiscing by large ellipsoidal apicalpores, hairy or glabrous, oblong or lanceolate, 2-celled; filamentsshort, usually slender and glabrous. Staminodes: usually absent,glabrous; styles 2 (or 1, bifid), usually glabrous; stigmas bifid at apex.Ovary: ovoid or globular, hairy or glabrous, usually 4-celled; ovules4, pendulous. Fruit: usually globose, 1-seeded berry (Halim et al.,2014), edible, spherical and one-seeded berries (Figure 1C)(Dhayalan et al., 2015). Many members of this genus aretraditionally used to treat different diseases. Some arescientifically investigated for various biological activities andphytoconstituents. Previously, reviews that focus on singlespecies, E undulata Thunb (Maroyi, 2017) and E. divinorumHiern (Omara et al., 2020) have been conducted. To the authors\u2019knowledge, no study reviewed the ethnopharmacological use,phytochemistry, and biological activities of the whole genus.MethodologyThis review aims to critically evaluate available research reportson the genus and systematically organize and present the results.The review summarizes the existing knowledge on theFIGURE 1(A) Euclea divinorum (B) Euclea natalensis (C) Euclea undulate.FIGURE 2Flowchart of reviews included and excluded.Frontiers in Pharmacology frontiersin.org02Taye et al. 10.3389/fphar.2023.1170145TABLE 1 Traditional uses of members of the genus Euclea.Species PartusedIndication Country ReferencesE. crispa R cough South Africa Schmidt et al. (2002)R constipation South Africa Chinsamy and Koitsiwe (2016)Swaziland Long (2005)B, F, L, R Diabetes South Africa,Swaziland, ZimbabwePalmer and Pitman (1972)Chinsamy and Koitsiwe, 2016; Schmidtet al., 2002; Masoga, 2020L Dysmenorrhoea South Africa Steenkamp (2003)R convulsions and epilepsy Zimbabwe Stafford et al. (2008)E. coriacea B Constipation, Stomach pains South africa Kose et al. (2015)R, L and S Gonorrhea Lesotho Mugomeri et al., 2014E.divinorumR HIV/AIDS-related diseases Zambia Chinsembu (2016)R urine retention Ethiopia Woldemedhin et al. (2017)L malaria, leprosy, gonorrhea, syphilis and tapeworm Ethiopia Geyid et al., 2005; Nanyingi et al., 2008R induce labour Kenya Kaingu et al. (2012)F abdominal upsets, skin, kidney and respiratory disorders Kenya Kigen et al. (2017)R convulsions Zimbabwe Sobiecki (2002)R schistosomiasis South African Sparg et al. (2000)E. kellau B splenic pain Tanzania Orzalesi et al. (1970)R Ancylostomiasis Tanzania Orzalesi et al. (1970)L snake-bite Orzalesi et al. (1970)E.natalensisR Diabetes South Africa; Kenya Deutschl\u00e4nder M. S. et al., 2009; Keterand Mutiso, 2012R Epilepsy South Africa Van Wyk and Gericke (2000)L Antidote for poisoning, snake bite Malawi Morris and Msonthi (1996)B Prostate cancer Uganda Omara et al. (2020)R Leprosy, syphilis, toothache South Africa Oosthuizen and Lall (2020)Sh and B chest pains, bronchitis, pleurisy, and asthma South Africa Oosthuizen and Lall (2020)R Herpes simplex virus 1 South Africa Lall et al. (2005a)Tuberculosis South Africa Lall and Meyer (2001)B schistosomiasis South Africa Sparg et al. (2000)E. racemosa R Warts of the rectum, Constipation Ethiopia D\u2019avigdor et al., 2014; Ayele et al., 2023RB Cancer Ethiopia Wube et al. (2005)RB toothache and malaria Uganda Neuwinger (2000)R cancer, abdominal pain and convulsive dysmenorrhoea Tanzania Neuwinger (2000)RB, L,S, BrDiabetes Kenya Keter and Mutiso (2012)E. schimper L gonorrhea, eczema and constipation, snake biting, scabies, leprosy, Tineacapitis, acne, warts, rheumatic pain and elephantiasisEthiopia Gelahun, 1989; Abebe and Ayehu, 1993;Mekonnen et al., 2018R febrile disease (fever, headache and sweating) Ethiopia Giday et al. (2003)B Dysmenorrhoea South Africa Steenkamp (2003)(Continued on following page)Frontiers in Pharmacology frontiersin.org03Taye et al. 10.3389/fphar.2023.1170145ethnobotanical use, phytochemistry, and pharmacological activity ofspecies belonging to the genus Euclea to bring the reader up to datewith the current literature. Articles on the species of the genus Eucleathat reported ethnobotanical uses, biological activities, and isolationand identification of compounds were included. It is attempted toinclude articles published from 1975\u20132023 while some articlespublished before 1975 were also included by considering theirimportance. In this review articles where the full text was notavailable in the database or even after contacting the author byemail were excluded (Figure 2).This review excluded unpublished results and publicationsunavailable online, articles written in languages other thanEnglish, and articles whose titles and abstracts did not containthe search terms. Chemical structures of only isolated andcharacterized compounds were provided, while structures ofcompounds identified from essential oils and other chemicalanalyses were not. Different databases, including PubMed,Google Scholar, Scopus, and Medline, were employed to searchliterature using \u201ckeywords such as \u201cEuclea\u201d, \u201cethnobotanical use\u201d,\u201cphytochemistry\u201d, and \u201cpharmacological activity\u201d dated up toDecember 2023.\u201dEthno pharmacological usesEthnomedicinal claims on the genus Euclea to treat severalailments are illustrated in Table 1. The genus Euclea is used totreat hypnosis, toothache, headache (Bapela et al., 2008; Babulaet al., 2009), chest complaints, bronchitis, pleurisy, chronicasthma, urinary tract infections, and venereal diseases (Lall &Meyer, 2000; Lall and Meyer, 2001; Weigenand et al., 2004; Kooyet al., 2006; Johanna, 2007; Bapela et al., 2008). An infusion of theroots of E. ceispa possesses antiepileptic activity (Dhayalan et al.,2015). The root bark of E. undulata is reported to be used for themanagement of body pains, diabetes, headache, and toothachewhile an infusion of its leaves is used for stomach problems ordiarrhea, and leaf decoction for tonsillitis (Deutschl\u00e4nder M.et al., 2009; Dhayalan et al., 2015; Maroyi, 2017). This plant is afolk medicine for diabetes in the Venda area, Limpopo Province(Deutschl\u00e4nder M. S. et al., 2009; Babiaka et al., 2015; Maroyi,2017). In the Western Cape, the root infusion of E. undulata isused as enemata or as an ingredient of inembe (herbal medicationregularly taken during pregnancy to ensure trouble-freeconfinement). Emesis or purgation is induced with rootpreparations (Deutschl\u00e4nder M. et al., 2009).The Zulu people use E. natalensis as a purgative (Lall andMeyer, 2001; Weigenand et al., 2004) and for abdominalcomplaints in the form of infusion (Deutschl\u00e4nder M. S. et al.,2009; Deutschl\u00e4nder, 2010). Its charred and powdered root isused treat leprosy, urinary tract infections, venereal diseases,dysmenorrhea, and ancylostomiasis among Shangaan people(Lall & Meyer, 2000; Lall and Meyer, 2001); Kooy et al., 2006;Deutschl\u00e4nder, 2010) while its root bark infusions for sores andwounds in South Africa (Lall and Meyer, 2001). Within theTonga people, the same part of this plant exhibits toothacheand headache relief (Deutschl\u00e4nder M. et al., 2009; Babiaka et al.,2015; Dhayalan et al., 2015).In Swaziland, the stem bark decoction of E. divinorum is afolk medicine for constipation (Amusan et al., 2007). The rootbark is used for diarrhea, convulsions, cancer, and skin diseases(Mebe et al., 1998; Babiaka et al., 2015). In Kenya, the root of thisplant is a remedy for chest pain, pneumonia, and internal bodyswelling (Woldemedhin et al., 2017). In Ethiopia, the roots andleaves of this plant are used for treating urinary retention,malaria, leprosy, gonorrhea, syphilis, and tapeworm (Feyissaet al., 2013; Woldemedhin et al., 2017). E. schimperi istraditionally prescribed for managing wounds, teeth infection,eye disorder, headache, gonorrhea, eczema, skin disorder, snakebiting, scabies, leprosy, and elephantiasis in Ethiopia (Mekonnenet al., 2018).PhytochemistryEuclea is a good source of naphthoquinones, pentacyclictriterpenes (Dagne et al., 1993; Joubert et al., 2006; Kwonet al., 2011; Dhayalan et al., 2015), flavonoids, naphthols(Dagne et al., 1993) and diosindigo (Dhayalan et al., 2015).Members of the genus Euclea contain primarilynaphtoquinones and the root/root bark of the plant is themain source of the naphtoquinones. Phytochemical screeningrevealed that the leaf of E. schimperi contains saponins,TABLE 1 (Continued) Traditional uses of members of the genus Euclea.Species PartusedIndication Country ReferencesE. undulata RB Diabetes South Africa Deutschl\u00e4nder M. et al., 2009;Deutschlander, 2010B, R Toothache Botswana Palmer and Pitman, 1972; Motlhanka andNthoiwa, 2013L Diarrhoea South Africa Deutschl\u00e4nder M. S. et al. (2009)S Chewing stick Zimbabwe Joshua et al., 2013AP, aerial part; B, bark; Br, Branch; F, flower; Fr, Fruit, L, leaf; R, root; RB, root bark; Sh, shoot; S, stem; Sd, Seed; WP, whole plant.Frontiers in Pharmacology frontiersin.org04Taye et al. 10.3389/fphar.2023.1170145TABLE 2 Naphthoquinones isolated from Euclea species.No. Name of the compound Species PlantpartStructure References1. 2-methylnaphthazarin E. pseudebenus R Ferreira et al., 1973; Dhayalan et al.,20152. 7-methyl-juglone E. undulata R Deutschl\u00e4nder M. et al., 2009;Mbaveng & Kuete, 2014; Botha, 20163E.natalensis R Mbaveng & Kuete, 2014;Deutschl\u00e4nderM. S. et al., 2009; Babulaet al., 20094E. natalensis S, Rand SdLall et al., 2005b; Joubert et al., 2006;Johanna, 2007; Bapela et al., 2008;Babiaka et al., 2015; Kooy et al., 20065E. divinorum Us Mebe et al., 1998; Babula et al., 20096E. divinorum R Al-fatimi (2019)7E. pseudebenus R Ferreira et al. (1973)8E. racemosassp. schimperiR Wube et al. (2005)9E. lanceolata RB Ferreira et al. (1974)3. 8,8\u2019-dihyd roxy-4,4\u2019-dimethoxy-6, 6\u2019-dimethyl-2,2\u2019- binaphthyl-l,l\u2019- quinoneE. lanceolata RB Ferreira et al. (1974)4. 8\u2019-hydroxydiospyrin E. lanceolata RB Ferreira et al. (1974)5. biramentaceone E. pseudebenus R Ferreira et al. (1973)6. diospyrin E. undulata R Deutschl\u00e4nder M. et al. (2009)E. crispa var crispa R,Fr Botha (2016)E. undulata Fr Botha (2016)E. natalensis S, Rand SdLall et al., 2005a; Joubert et al., 2006;Johanna, 2007; Bapela et al., 2008;Babiaka et al., 2015E. pseudebenus Us Dhayalan et al. (2015)E. divinorum R Al-fatimi (2019)E. natalensis Us Deutschl\u00e4nder M. S. et al. (2009)(Continued on following page)Frontiers in Pharmacology frontiersin.org05Taye et al. 10.3389/fphar.2023.1170145TABLE 2 (Continued) Naphthoquinones isolated from Euclea species.No. Name of the compound Species PlantpartStructure References7. eucleanal E. divinorum L Ng\u2019ang\u2019a et al., 20128. eucleanal B E. divinorum L Mwihaki Ng\u2019ang\u2019a et al., 20129. eucleanal A E. divinorum L Mwihaki Ng\u2019ang\u2019a et al., 201210. euclein (3, 6\u2019-dimer of 7-methyljuglone.) E.pseudebenus R Ferreira et al. (1973)11. isodiospyrin E. undulata Fr Deutschl\u00e4nder M. et al., 2009; Botha,2016E. crispa Fr Botha (2016)E. natalensis Us Kooy et al., 2006; Wube et al., 2005E. racemosassp. schimperiR Wube et al., 2005; Al-fatimi, 201912. mamegakinone E. natalensis Us Kooy et al., 2006E. natalensis Us Deutschl\u00e4nder M. S. et al. (2009)E. pseudebenus R Ferreira et al., 197E. racemosassp. schimperiR Wube et al. (2005)E. natalensis, E. cripsa,and E. schimperiUs Dhayalan et al. (2015)E. divinorum R Al-fatimi (2019)E. lanceolata RB Ferreira et al. (1974)13. natalonone E. crispa subsp. Crispa Us Kwon et al. (2011)(Continued on following page)Frontiers in Pharmacology frontiersin.org06Taye et al. 10.3389/fphar.2023.1170145terpenoids, tannins, steroids, polyphenols, and flavonoids afterextraction with methanol and chloroform (Mekonnen et al.,2018). Aqueous and 80% methanol root extract of E.divinorum had shown to contain saponins, flavonoids,glycosides, steroids, tannins, and terpenoids (Woldemedhinet al., 2017; Al-fatimi, 2019) but alkaloids and anthraquinoneswere absent (Woldemedhin et al., 2017). On the other hand, theroot bark of this plant produces alkaloids, terpenoids, flavonoids,tannins, and saponins (Shumba, 2018). Methanol leaf and stemextracts of E. undulata contained alkaloids, diterpenes,glycosides, phytosterols, reducing sugars, saponins, andtannins (Maroyi, 2017). Essential oils, saponins, terpenoidderivatives, alkaloids, and flavonoids are the constituents of E.crispa subsp. crispa (Kwon et al., 2011).NaphthoquinoneQuinones are one of the plant-derived secondary metabolites.Based on the number of benzene rings in the structural fused andskeleton, they are mainly classified as naphthoquinone,phenanthrenequinone, anthraquinone, and benzoquinone (Demir,2020). Naphthoquinones are phenolic compounds derived fromnaphthalene occurring in plants (common) and fungi (Mbaveng &Kuete, 2014; Botha, 2016). They were mainly detected from the rootbarks of the genus Euclea (Khan, 1985). Naphthoquinone isolatedfrom the genus Euclea is presented in Table 2.FlavonoidsFlavonoids are phenolic compounds having two benzene ringslinked through a heterocyclic pyrane ring (Shumba, 2018).Quercetin, kaempferol (Al-fatimi, 2019), new aromadendrin-3-O-\u03b2-L-arabinopyranoside (17), and known flavonoids such as catechin(Dagne et al., 1993; Mebe et al., 1998), myricetin-3-O-\u03b1-L\u2013rhamnopyranoside (21) and quercetin-3-O-\u03b1-L-rhamnopyranoside (22) were isolated from the extract of ethanolaerial part of E. divinorum (Dagne et al., 1993), (Table 3). Acetoneleaves extract of E. racemosa ssp. Schimperi yields quercetrin,myricitrin, myricetin-3-O-arabinopyranoside (20) and rutin (23),(Asres et al., 2006).HPLC detects large amounts of myricitrin and small amounts ofisoquercitrin and quercitrin in E. schimperi (Mueller-harvey et al.,1987). Root bark extracts of E. undulata (acetone) (Deutschl\u00e4nder,2010; Babiaka et al., 2015; Botha, 2016), E. divinorum (chloroform)and E. undulata (acetone) resulted in the isolation of epicatechin(19) and catechin (18) respectively (Babiaka et al., 2015).TABLE 2 (Continued) Naphthoquinones isolated from Euclea species.No. Name of the compound Species PlantpartStructure References14. neodiospyrin E. natalensis S, Rand SdJoubert et al., 2006; Johanna, 2007;Bapela et al., 2008; Babiaka et al., 201515E. racemosassp. schimperiR Wube et al. (2005)15. octahydroeuclein E. natalensis RB Weigenand et al., 2004; Lall et al., 200616. shinanolone E. natalensis RB Weigenand et al., 2004; Kooy et al.,2006; Lall et al., 200618E. natalensis S, Rand SdJoubert et al., 2006; Johanna, 2007;Bapela et al., 200819E. divinorum Us Mebe et al. (1998)20E.racemosassp. schimperiR Wube et al. (2005)21E. natalensis Us Kooy et al., 2006B, bark; F, flower; Fr, Fruit; R, root; RB, root bark; S, shoot; Sd, Seed; Us, Unspecified.Frontiers in Pharmacology frontiersin.org07Taye et al. 10.3389/fphar.2023.1170145TABLE 3 Flavonoids isolated from Euclea species.No. Name of the compound Species Plant part Structure References17 aromadendrin-3-O-\u03b2-LarabinopyranosideE. divinorum A Dagne et al., 199318 catechin E. divinorum RB Babiaka et al. (2015)19 epicatechin E. undulate RB Deutschl\u00e4nder, 2010; Babiaka et al., 2015; Botha,201620 myricetin-3-O-arabinopyranoside E. racemosa L Asres et al. (2006)21 myricetin-3-O-\u03b1-L \u2013rhamnopyranoside E. divinorum A Dagne et al., 199322 quercetin-3-O-\u03b1-L-rhamnopyranoside E. divinorum A Dagne et al., 1993(Continued on following page)Frontiers in Pharmacology frontiersin.org08Taye et al. 10.3389/fphar.2023.1170145Hyperoside, quercitrin, epicatechin, catechins and gallocatechinwere isolated from the leaves of E. crispa subsp. Crispa(Rademana et al., 2019).TerpenoidsTriterpenes are a group of natural products, derived fromisoprene units. In nature, triterpenoids are often existed as tetra-or penta-cyclic structures but some acyclic, mono-, bi-, tri- and hexaacyclic. As described in Table 4, Lupeol, lupine, botulin andoleanolic acid are some examples of pentacyclic triterpenoids(Furtado et al., 2017). Triterpenoids were detected from root andstem barks of E. natalensis (Khan, 1985). Phytol (0.66%) andsqualene (5.85%) were detected from hexane extract of E. crispausing GC-MS (Palanisamy & Ashafa, 2018).MiscellaneousThe following bioactive compounds with their compositionwere identified from hexane extract of E. crispa using GC-MS:tetracosane (14.98%), dodecane (10.76%), 2-ethyl-1-decanol(8.00%), tridecane (7.53%), diphenyl vinyl phosphine (6.38%),triacontane (5.27%), 2,6-dimethylheptadec-ane (5.02%), docosane(3.68%), tetradecane (3.59%), 1-hepten-3-ol (2.63%), orthotolidine(2.31%), Phenyl glucuronide (2.25%), 5-tridecy-lbenzene-1,3-diol(1.90%), and Pentadec-ane (1.68%) (Palanisamy & Ashafa, 2018).Vitamin E, fatty acid methyl esters such as saturated (C14, C20) andunsaturated (C16, C18:1, C18:2, and C18:3 were isolated from twigs andleaves of E. undulate (Maroyi, 2017). VTLC identified gallic andellagic acid esters in E. schimperi (Mueller-harvey et al., 1987).Biological activitiesAntimicrobial activityThe acetone and aqueous extract of E. natalensis inhibited thegrowth of Bacillus cereus, B. pumilus, B. subtilis, Micrococcuskristinae, and Staphylococcus aureus at concentrations rangingbetween 0.1 and 6.0 mg/mL (Lall and Meyer, 2000). Isolatedcompounds from the root extract also demonstrated a significantantimicrobial effect. Diospyrin and 7-methyljuglone were moreeffective against Gram-positive bacteria than Gram-negativebacteria.Shinanolone, 7-methyljuglone, diospyrin, isodiospyrin andneodiospyrin in the genus Euclea especially E. natalensis arepotent for the treatment of both drug-sensitive and resistanttuberculosis (Joubert et al., 2006; Johanna, 2007; Bapela et al.,2008; Babula et al., 2009; Babiaka et al., 2015). On the other hand,diospyrin, lupeol, betulin and 7-methyl juglone presented in E.natalensis has inhibitory activity against drug-sensitive M.tuberculosis at MIC of 8.0 and 0.5 mg/mL respectively(Maroyi, 2017). The intracellular and extracellular inhibitionof the latter compound is greater than that of the anti-tuberculosis drugs streptomycin and ethambutol (Lall et al.,2005b; Mcgaw et al., 2008).7-methyl juglone and mamegakinone are effective against M.tuberculosis (Kooy et al., 2006), Neisseria gonorrhoeae, Shigelladysenteriae and Shigella flexneri. Aqueous and acetone extracts ofthe roots of E. natalensis inhibited the growth of Mycobacteriumtuberculosis at MIC value of 0.5 mg/mL while MIC values for B.cereus, B. pumilus, B. subtilis,M. kristinae and S. aureus ranged from0.1\u20136.0 mg/mL (Lall & Meyer, 2000; Lall and Meyer, 2001). 7-methyl juglone is also effective against Saccharomyces cerevisiae,M. bovis,M. smegmatis andM. fortuitum (Mbaveng & Kuete, 2014).Due to Shinanolone, E. natalensis inhibits the growth of Gram-positive bacterial strains and a drug-sensitive strain of M.tuberculosis at a concentration of 0.1 mg/mL (Weigenand et al.,2004).Ethanolic extract of E. crispa leaves elicit antimicrobial activity withmaximum inhibition zone against Staphylococcus aureus, Streptococcusaureus, Escherichia coli, Klebsiella pneumonia, Aspergillus niger andAspergillus terreus (Palanisamy et al., 2019). Previous literaturesdemonstrated that E. lanceolata, E. undulata and E. multiflorapossess antifungal activity due to the presence of lawsone, jugloneand 7-methyljuglone (Lall &Meyer, 2000; Lall andMeyer, 2001). Eucleanatalensis comprises \u03b2-sitosterol (Lall et al., 2006; Moosavi et al., 2020),20 (29)-lupine-3\u03b2-isoferulic and shinanolone that have inhibitoryactivity against Aspergillus niger at 0.01 mg/mL. The formercompound and octahydro euclein significantly show fungistaticactivity against C. cladosporioides at 0.01 mg/mL. Besides this,octahydro euclein present in this plant is very effective forPhytophthora sp. at 0.1 mg/mL (Lall et al., 2006).TABLE 3 (Continued) Flavonoids isolated from Euclea species.No. Name of the compound Species Plant part Structure References23 rutin E. racemosa L Asres et al. (2006)A, arial; RB, root bark; L, leaf.Frontiers in Pharmacology frontiersin.org09Taye et al. 10.3389/fphar.2023.1170145TABLE 4 Terpenoids isolated from Euclea species.No Name of the compound Species PlantpartStructure References24 20 (29)-lupene-3\u03b1-isoferulate E. natalensis RB Weigenand et al. (2004)25 20 (29)-lupene-3\u03b2-isoferulate E. natalensis RB Lall et al. (2006)26 3-oxo-oleanolic acid E. crispasubsp. crispaUs Kwon et al. (2011)27 3\u03b2-(5-hydroxyferuloyl)lup-20(30)-eneE. crispasubsp. crispaUs Kwon et al. (2011)(Continued on following page)Frontiers in Pharmacology frontiersin.org10Taye et al. 10.3389/fphar.2023.1170145TABLE 4 (Continued) Terpenoids isolated from Euclea species.No Name of the compound Species PlantpartStructure References28 \u03b1-amyrin E. kellau L Orzalesi et al. (1970)29 \u03b1-amyrin-3O-\u00df-(5-hydroxy) ferulicacidE. undulate RB Deutschl\u00e4nder, 2010; Botha, 201630 betulin E. natalensis RB Weigenand et al., 2004; Lall et al., 2005b; Lallet al., 2006E. divinorum RB Mebe et al., 1998; Al-fatimi, 2019E. kellau Br Orzalesi et al. (1970)E. latideus R Philip et al. (2018)E. undulata RB Deutschl\u00e4nder, 2010E. crispasubsp. crispaRB Rademana et al. (2019)31 farnesol E. crispa L Palanisamy et al. (2020)(Continued on following page)Frontiers in Pharmacology frontiersin.org11Taye et al. 10.3389/fphar.2023.1170145TABLE 4 (Continued) Terpenoids isolated from Euclea species.No Name of the compound Species PlantpartStructure References32 germanicol E. divinorum RB Kilonzo et al. (2019)33 lupene E. divinorum RB Mebe et al., 1998; Al-fatimi, 201934 lupeol E. natalensis RB Weigenand et al., 2004; Lall et al., 2005a; Lallet al., 2006E. divinorum RB Mebe et al., 1998; Al-fatimi, 2019E. kellau Br Orzalesi et al. (1970)E. latideus R Philip et al. (2018)E. undulata RB Deutschl\u00e4nder, 2010; Botha, 2016(Continued on following page)Frontiers in Pharmacology frontiersin.org12Taye et al. 10.3389/fphar.2023.1170145TABLE 4 (Continued) Terpenoids isolated from Euclea species.No Name of the compound Species PlantpartStructure References35 ursolic acid E. kellau Br, L Orzalesi et al. (1970)36 ursolic acid lactone E. kellau Br, L Orzalesi et al. (1970)37 uvaol E. kellau L Orzalesi et al. (1970)38 \u03b2-sitosterol E. natalensis RB Lall et al., 2006; Moosavi et al., 202039 \u03b3-sitosterol E. divinorum RB Kilonzo et al. (2019)Br, Branch; L, leaf; R, root; RB, root bark; Us, Unspecified.Frontiers in Pharmacology frontiersin.org13Taye et al. 10.3389/fphar.2023.1170145Ethyl acetate root extract of E. divinorum has inhibitory activityagainst Gram-negative bacteria like E. coli but is ineffective for S.aureus. Alkaloids and terpenoids in this plant contribute to this kindof antibacterial activity (Shumba, 2018). The MIC values of theextracts of E. divinorum against bacterial activity for root bark ethylacetate and leaf aqueous ranges from 0.048-0.871 mg/mL and 0.781-1.562 mg/mL respectively. The first extract is very effective against S.typhi followed by stem bark aqueous and root bark petroleum etherextract against S. aureus (Kilonzo et al., 2019).The non-polar dichloromethane root extract of E. divinorumroot bark has better antifungal activity than the nystatin forAbsidia corymbifera, Aspergillus fumigatus, Candida krusei,Microsporum gypseum, Mucor sp. and Trichophytonmentagrophytes. This activity is maintained with lupeol,lupine, botulin, 7-methyl juglone, diospyrin, iso diospyrin andshinalone (Al-fatimi, 2019).Antiviral activityThe acetone extract of E. natalensis demonstrated moderateantiviral activity against HSV-1, at concentrations of 0.1\u20130.02 mgml\u22121 (Lall et al., 2005a). In a study conducted by Tshikalange et al.(2007) 7-methyljuglone (potent), diospyrin, neodiospyrin,isodiospyrin, and 6-methyljuglone isolated from that E. natalensisexhibited HIV-1 reverse transcriptase activity at the concentrationsranging from 25 to 50 \u03bcg/mL. The leaf extract of E. schimperi showedgood antiviral activity against Influenza A virus and herpes simplexvirus (HSV-1) with IC50 values of 6.22 6 \u03bcg/mL and 67.5 \u03bcg/mL,respectively (Gebre-Mariam et al., 2006).Antimalarial activityAqueous, dichloromethane, and methanol leaf and twigextracts of E. undulata have shown antimalarial activityagainst Plasmodium falciparum using the parasite lactatedehydrogenase assay (Maroyi, 2017). E. latideus is alsoeffective against P. falciparum especially for the chloroquineresistant strain of P. falciparum due to the presence of lupeol,betulin, and 3\u03b2-(5-hydroxy feruloyl) lup-20 (30)-ene (Philipet al., 2018). The dichloromethane and methanol (1:1) rootand leaf extracts of E. natalensis demonstrated promisingactivity in a research by Clarkson et al. (2004) employing theparasite lactate dehydrogenase assay, with (IC50) values of5.1 and 5.3 mg/mL, respectively, against P. falciparum. Astudy done by Philip et al. (2018) indicated that the extractsand isolated compounds from E. latideus demonstratedantiplasmodial activity against chloroquine sensitive andchloroquine resistant strains of P. falciparum. The leaves of E.natalensis also showed antiplasmodial activity with an IC50 of25.6 \u03bcg/mL (Tajuddeen et al., 2022). The in vivo antimalarialassay of the aqueous root extract of E. divinorum possessedsignificant parasitemia suppression (Girmaw and Engidawork,2022).Antidiabetic activityE. undulata containing \u03b1-amyrin-3-O-\u03b2-(5-hydroxy) ferulicacid inhibits \u03b1-glucosidase and epicatechin lowers glucose levelsin the blood (Botha, 2016). Phenolic acids and flavonoids of E.crispa inhibit alpha amylase with IC50 values of 1.001 mg/mLand 1.65 mg/mL (Tinevimbo, 2017). Lowering of blood glucosecan be achieved with acetone root bark extracts of E. undulata bydisplaying a glucose uptake of 162.2% by changing liver cells at50 mg/mL (Maroyi, 2017). E. coriacea contains phytosterols thatpossess antidiabetic activity (Mugomeri et al., 2014). Acetoneroot bark extracts of E. undulata effectively reduced fastingblood glucose levels, raised cholesterol, and triglyceride levelsto close to normal without causing weight gain in an in vivomodel of streptozotocin-nicotinamide-induced type-2 diabetes(Deutschl\u00e4nder et al., 2012).Antioxidant activityEthanolic root bark and leaf extracts of E. crispa have radicalscavenging activity because of flavonoids, phenolics (Tinevimbo,2017) and (6E, 10E)-2, 6, 24-trimethylpentane cosa-2, 6, 10-triene isolated from the leaves of E. crispa exhibited potentantioxidant activity (Palanisamy et al., 2019). The leaves of E.crispa were tested for antioxidant activity and showedIC50 values of 113.79, 109.59, and 116.65 \u03bcg/mL for DPPH,hydroxyl and nitric oxide radical scavenging assays. Farnesolcontributes to such activity (Palanisamy et al., 2020). At a2000 mg/mL concentration, E. divinorum inhibits DPPH by82.5%, 74.5% and 62.5% for the methanol fraction, aqueousfraction and crude extract, respectively (Feyissa et al., 2013).Fatty acids, flavonoids, and phenolics of E. undulata showedantioxidant activity using the DPPH, ABTS and FRAP assays(Maroyi, 2017). The free radical scavenging effect of methanoland chloroform leaf extracts of E. schimperi was demonstrated.The methanol and chloroform extracts were able to scavenge theDPPH radical with a percentage scavenging activity of 85.4% and58.5% at the concentration of 40 \u03bcg/mL, respectively (Mekonnenet al., 2018).Anticancer activityThe leaves of E. crispa subsp. crispa extract exhibited anti-proliferative activity on human breast adenocarcinoma (MCF-7)and human epidermoid carcinoma (A431) cell lines with IC50values of 45.7 \u03bcg/mL and 41.8 \u03bcg/mL, respectively (Rademanaet al., 2019). 7-methyl juglone and 3\u03b2-(5-hydroxy feruloyl) lup-20 (30)-ene, which are the main constituents of E. divinorum,showed anticancer effects against human breast cancer, coloncancer, fibrosarcoma, nasopharyngeal carcinoma, lung cancer,and human melanoma (Mebe et al., 1998). Diterpenes isolatedfrom E. coriacea has been reported to possess an anticancer effectin human cells (Mugomeri et al., 2014). 7-Methyl jugloneisolated from E. racemosa ssp. schimperi has been described topossess significant cytotoxic properties against human coloncarcinoma cells (Wube et al., 2005). Euclea natalensis alsocontains this compound that has anticancer activity on severalcancer cell lines, such as KB, Lu1, and LNCaP (Mbaveng & Kuete,2014).Other activitiesE. coriacea contains phytosterols that possess anti-inflammatory and anti-pain activity (Mugomeri et al., 2014). Astudy showed that E. natalensis shoot extract has in vivohepatoprotective activity by reducing the level of alanineFrontiers in Pharmacology frontiersin.org14Taye et al. 10.3389/fphar.2023.1170145transaminase liver enzyme by 15% (50 mg/kg) and 40%(100 mg/kg). This plant also provides an immunomodulatoryactivity by increasing T-helper 1 cell cytokines such asInterleukin 2, Interleukin 12, and Interferon \u03b1 by 12 fold anddecreasing the T-helper 2 cell cytokine, interleukin 10 by 4 foldwhen compared to baseline cytokine production (Lall et al., 2016).The in vivo evaluation of the antidiuretic activity of E. divinorumrevealed that the aqueous and methanol root extract of the plantpossessed a significant diuretic activity by increasing urine volumeand electrolyte excretion (Woldemedhin et al., 2017). Feyissa et al.(2013) demonstrated that the crude extract and solvent fractions ofE. divinorum leaves restored gentamicin-induced nephrotoxicity bydecreasing tubular necrosis, serum and oxidant markers and byincreasing in antioxidant molecules. The methanol fractionprovided the most renoprotection, implying that semi-polarantioxidant principles may be involved.Acute toxicity, gentotoxicity and cytotoxiciyAcute toxicity studies of the crude and methanolic extract of E.divinorum leaves indicated that it was safe when administered orallyat 2000 mg/kg (Feyissa et al., 2013; Woldemedhin et al., 2017). Aftera period of 72 h, the animals tolerated the administered dose, andthere were no appreciable changes in behavior such as motoractivity, diarrhoea, breathing, alertness, restlessness, convulsions,coma and appearance. Since no mortality was recorded within14 days, the lethal dose (LD50) was indicated to be more than2000 mg/kg. Shauli, (2023) evaluated the acute and sub-acute oraltoxicity of E. natalensis and the results demonstrate that no treatmentrelated deaths or toxic signs were observed. Another study done byAyele et al. (2023) revealed that E. racemosawas safe after oral toxicitystudy with LD50 greater than 2000 mg/kg. E. latideus is considered as anon-toxic plant since acute toxicity studies showed that crude extractshad LD50 > 5,000 mg/kg (Kodi et al., 2018).Taylor et al. (2003) investigated genotoxicity in humanperipheral blood lymphocytes of South African medicinal plants.The results reported that the dichloromethane root extract of E.divinorum induced DNA damage (more cells with high tail DNAcontent), which was however lower than that of the positive control(1 mM potassium bichromate). However, the bark extract of E.natalensis showed positive results for genotoxicity in themicronucleus test.ConclusionThe genus Euclea is well known for its use in the treatment ofdiabetic and body pain manifestations. The traditional claimswere justified by different biological evaluations. The genusEuclea is known to be a source of biologically activecompounds. More than 40 compounds were isolated from thegenus and naphthoquinones, pentacyclic triterpenes andflavonoids are the most abundant bioactive secondarymetabolites which are responsible for the observed biologicalactivity. Most of these secondary metabolites are found in theroots and root bark while some in fruit, seeds, leaves and shoots.According to the present review, it has been noted that thepotential uses of the species in the treatment of viral infectionsand nerve-related diseases have not been scientifically explored.We believe the scientific community researching on the genuswill benefit from the material compiled in this review.Author contributionsAT designed the study, conducted the literature review,extracted relevant information to the study, write themanuscript. AK and GB contributed in writing, editing andrevising the manuscript. All authors read and approved themanuscript.Conflict of interestThe authors declare that they no conflict of financial interests orpersonal relationships that could have appeared to influence thework reported in this review.Publisher\u2019s noteAll claims expressed in this article are solely those of the authorsand do not necessarily represent those of their affiliatedorganizations, or those of the publisher, the editors and thereviewers. Any product that may be evaluated in this article, orclaim that may be made by its manufacturer, is not guaranteed orendorsed by the publisher.ReferencesAbebe, D., and Ayehu, A. (1993). \u201cMedicinal plants and enigmatic health practices ofNorthern Ethiopia,\u201d in Addis ababa, Ethiopia: B. S. P. E, 511.Ahvazi, M., Charkhchiyan, M., Khalighi-Sigaroodi, F., Mojab, F., Mozaffarian, A., andZakeri, H. (2012). Introduction of medicinal plants species with the most traditionalusage in Alamut Region. Iran. J. Pharm. Res. 11 (1), 185\u2013194.Al-fatimi, M. (2019). Antifungal activity of Euclea divinorum root and study of itsethnobotany and phytopharmacology. Processes 7, 680. doi:10.3390/pr7100680Amusan, O., Sukati, N., Dlamini, P., and Sibandze, F. (2007). Some Swaziphytomedicines and their constituents. Afr. J. Biotechnol. 6 (3), 267\u2013272.Asres, K., Gibbons, S., and Bucar, F. (2006). Radical scavenging compounds fromEthiopian medicinal plants. Ethiop. Pharm.J. 24, 23\u201330. doi:10.4314/epj.v24i1.35095Ayele, A. G., Mulugeta, B., and Wondmkun, Y. T. (2023). Evaluations of the in vivolaxative effects of aqueous root extracts of Euclea racemosa L. in mice.Metab. Open 17,100222. doi:10.1016/j.metop.2022.100222Babiaka, S., Ntie-kang, F., Ndingkokhar, B., Mbah, J., Sippl, W., and Yong, J. (2015).The chemistry and bioactivity of southern african flora II: Flavonoids, quinones andminor compound classes. RSC Adv. 5, 57704\u201357720. doi:10.1039/c5ra05524eBabula, P., Adam, V., Havel, L., and Kizek, R. (2009). Noteworthy secondarymetabolites naphthoquinones \u2013 their occurrence, pharmacological properties andanalysis. Curr. Pharm. Anal. 5, 47\u201368. doi:10.2174/157341209787314936Bapela, J., Kuete, V., Toit, E., Meyer, M., and Lall, N. (2008). Fertilization-inducedchanges in growth parameters and antimycobacterial activity of Euclea natalensis(Ebenaceae). S. A. J. Bot. 74, 244\u2013250. doi:10.1016/j.sajb.2007.11.011Bapela, M. J. (2008). Variation of active constituents in Euclea natalensis based onseedling stages, seasons, and fertilizers(Doctoral dissertation, University of Pretoria).Botha, L. E. (2016). Investigating the production of secondary metabolites effective inlowering blood glucose levels in Euclea Undulata Thunb. Var Myrtina(Ebenaceae)(Doctoral dissertation).Frontiers in Pharmacology frontiersin.org15Taye et al. 10.3389/fphar.2023.1170145Chinsamy, M., and Koitsiwe, M. (2016). Traditional knowledge of medicinal andfood plant uses for sustainable community livelihoods: A case of batswanacommunities in South Africa. J. Soc. Sci. 46 (2), 146\u2013154. doi:10.1080/09718923.2016.11893522Chinsembu, K. C. (2016). Ethnobotanical study of plants used in the management ofHIV/AIDS-related diseases in Livingstone, Southern Province, Zambia. Evid. BasedComplement. Altern. Med. 2016, 4238625. Article ID 4238625. doi:10.1155/2016/4238625Clarkson, C., Maharaj, V. J., Crouch, N. R., Grace, O. M., Pillay, P., Matsabisa, M. G.,et al. (2004). In vitro antiplasmodial activity of medicinal plants native to or naturalisedin South Africa. J. Ethnopharmacol. 92 (2-3), 177\u2013191. doi:10.1016/j.jep.2004.02.011Dagne, E., Alemu, M., and Sterner, O. (1993). Flavonoids from Euclea divinorum.Bull. Chem. Soc. Ethiop. 7 (2), 87\u201392.D\u2019avigdor, E., Wohlmuth, H., Asfaw, Z., and Awas, T. (2014). The current status ofknowledge of herbal medicine and medicinal plants in Fiche, Ethiopia. J. Ethnobiol.Ethnomedicine 10 (1), 38\u201333. doi:10.1186/1746-4269-10-38Demir, Y. (2020). Naphthoquinones, benzoquinones and anthraquinones:Molecular docking, ADME and inhibition studies on human serumparaoxonase-1 associated with cardiovascular diseases. Drug Dev. Res. 81 (5),628\u2013636. doi:10.1002/ddr.21667Deutschl\u00e4nder, M., Lall, N., and Venter, M. (2009). Plant species used in the treatmentof diabetes by South African traditional healers: An inventory. Pharm. Biol. 47 (4),348\u2013365. doi:10.1080/13880200902752959Deutschl\u00e4nder, M. S., Van de Venter, M., Roux, S., Louw, J., and Lall, N. (2009).Hypoglycaemic activity of four plant extracts traditionally used in South Africa fordiabetes. J. Ethnopharmacol. 124 (3), 619\u2013624. doi:10.1016/j.jep.2009.04.052Dhayalan, M., Jegadeeshwari, A., and Gandhi, N. (2015). Biological activity sourcesfrom traditionally used Tribe and herbal plants material.Asian J. Pharm. Clin. Res. 8 (6),11\u201323.Ferreira, A., Lopes, M., Costa, M., and Alves, C. (1974). Eucleolatin: A dimeric methylnaphthazarin from Euclea lanceolata. Phytochemistry 13, 499\u2013501. doi:10.1016/s0031-9422(00)91243-3Ferreira, M., Costa, M., Alves, A., and Lopes, M. (1973). Euclein: A newnaphthaquinone from Euclea pseudebenus. Phytochemistry 12, 433\u2013435. doi:10.1016/0031-9422(73)80035-4Feyissa, T., Asres, K., and Engidawork, E. (2013). Renoprotective effects of the crudeextract and solvent fractions of the leaves of Euclea divinorum Hierns againstgentamicin-induced nephrotoxicity in rats. J. Ethnopharmacol. 145 (3), 758\u2013766.doi:10.1016/j.jep.2012.12.006Furtado, N., Pirson, L., Edelberg, H., Miranda, L., Loira-Pastoriza, C., Preat, V., et al.(2017). Pentacyclic triterpene bioavailability: An overview of in vitro and in vivo studies.Molecules 22 (3), 1\u201324.Gebre-Mariam, T., Neubert, R., Schmidt, P. C., Wutzler, P., and Schmidtke, M.(2006). Antiviral activities of some Ethiopian medicinal plants used for the treatment ofdermatological disorders. J. Ethnopharmacol. 104 (1-2), 182\u2013187. doi:10.1016/j.jep.2005.08.071Gelahun, A. (1989). \u201cEtse debdabe, Ethiopian traditional medicine,\u201d in Biologydepartment, science faculty, addis ababa university. Editor D. Sebsebe, 64\u2013123.Geyid, A., Abebe, D., Debella, A., Makonnen, Z., Aberra, F., Teka, F., et al. (2005).Screening of some medicinal plants of Ethiopia for their anti-microbial properties andchemical profiles. J. Ethnopharmacol. 97 (3), 421\u2013427. doi:10.1016/j.jep.2004.08.021Giday, M., Asfaw, Z., Elmqvist, T., and Woldu, Z. (2003). An ethnobotanical study ofmedicinal plants used by the Zay people in Ethiopia. J. Ethnopharmacol. 85 (1), 43\u201352.doi:10.1016/s0378-8741(02)00359-8Girmaw, F., and Engidawork, E. (2022). In vivo anti-malarial activity of the aqueousroot extract of Euclea divinorum hiern (Ebenaceae) against Plasmodium berghei ANKA.Evid. Based Complement. Altern. Med. 2022, 2640648. Article ID 2640648. doi:10.1155/2022/2640648Gowdhami, T., Rajalakshmi, A. K., and Sugumar, N. (2015). Pharmacognostical andpreliminary phytochemical screening of the leaf extract of Jasminum auriculatum Vahl.Int. Lett. Nat. Sci. 43, 69\u201375. doi:10.56431/p-23h92lHalim, A., Mohamed, A., Habeeb, R., Azer, A., Safwat, R., and Hafeez, A. (2014).Taxonomic revision of Ebenaceae in Egypt. Curr. Sci. Int. 3 (4), 414\u2013425.Jackson, P. W., and Miller, J. (2015). Developing a world flora online - a2020 challenge to the world\u2019s botanists from the international community.Rodrigu\u00e9sia 66 (4), 939\u2013946. doi:10.1590/2175-7860201566402Joubert, A., Kooy, F., Meyer, J. M., and Lall, N. (2006). HPLC in the comparativestudy of the content of naphthoquinones (quinonoid constituents) in Eucleaspecies of South Africa. Chromatographia 64 (7/8), 399\u2013403. doi:10.1365/s10337-006-0055-zKaingu, C. K., Oduma, J. A., and Kanui, T. (2012). Preliminary investigation ofcontractile activity of Ricinus communis and Euclea divinorum extracts on isolatedrabbit uterine strips. J. Ethnopharmacol. 142 (2), 496\u2013502. doi:10.1016/j.jep.2012.05.026Karunamoorthi, K., Jagajeevanram, K., Vijayalakshmi, J., and Mengistie, E. (2013).Traditional medicinal plants: A source of phytotherapeutic modality in resource-constrained health care settings. J. Evid. Based Complement. Altern. Med. 18 (1),67\u201374. doi:10.1177/2156587212460241Keskin, C. (2018). Medicinal plants and their traditional uses. J. Adv. plant Biol. 1 (2),8\u201312. doi:10.14302/issn.2638-4469.japb-18-2423Keter, L. K., and Mutiso, P. C. (2012). Ethnobotanical studies of medicinal plants usedby traditional health practitioners in the management of diabetes in lower easternProvince, Kenya. J. Ethnopharmacol. 139 (1), 74\u201380. doi:10.1016/j.jep.2011.10.014Kigen, G., Kipkore, W., Wanjohi, B., Haruki, B., and Kemboi, J. (2017). Medicinalplants used by traditional healers in sangurur, elgeyo marakwet county, Kenya.Pharmacogn. Res. 9 (4), 333\u2013347. doi:10.4103/pr.pr_42_17Kilonzo, M., Rubanza, C., Richard, U., and Sangiwa, G. (2019). Antimicrobialactivities and phytochemical analysis of extracts from Ormocarpum trichocarpumand Euclea divinorum used as traditional medicines in Tanzania. Tanzan J. HealthRes. 21 (2), 1\u201312. doi:10.4314/thrb.v21i2.6Kodi, P., Mwangi, M. E., Cheplogoi, P. K., Langat, M., and Hoseah, M. A. (2018). Invitro antiplasmodial and toxicity activities of crude extracts and compounds fromEuclea latideus (Ebenaceae). Int. J. Biochem. Res. Rev. 21 (1), 1\u201322. doi:10.9734/ijbcrr/2018/39603Kose, L. S., Moteetee, A., and Van Vuuren, S. (2015). Ethnobotanical survey ofmedicinal plants used in the Maseru district of Lesotho. J. Ethnopharmacol. 170,184\u2013200. doi:10.1016/j.jep.2015.04.047Kwon, H., Cha, J., Park, J., Chun, Y., Moodley, N., Maharaj, V., et al. (2011). Rapididentification of bioactive compounds reducing the production of amyloid \u03b2 -Peptide (A\u03b2) from South African plants using an automated HPLC/SPE/HPLC coupling system.Biomol. Ther. 19 (1), 90\u201396. doi:10.4062/biomolther.2011.19.1.090Lall, N., Kumar, V., Meyer, D., Gasa, N., Hamilton, C., Matsabisa, M., et al. (2016). Invitro and in vivo antimycobacterial, hepatoprotective and immunomodulatory activityof Euclea natalensis and its mode of action. J. Ethnopharmacol. 194, 740\u2013748. doi:10.1016/j.jep.2016.10.060Lall, N., and Meyer, J. J. M. (2001). Inhibition of drug-sensitive and drug-resistantstrains of Mycobacterium tuberculosis by diospyrin, isolated from Euclea natalensis.J. Ethnopharmacol. 78 (2-3), 213\u2013216. doi:10.1016/s0378-8741(01)00356-7Lall, N., Meyer, J. J. M., Taylor, M. B., and van Staden, J. (2005b). Anti-HSV-1 activityof Euclea natalensis. S. Afr. J. Bot. 71 (3-4), 444\u2013446. doi:10.1016/s0254-6299(15)30118-6Lall, N., andMeyer, J. M. (2000). Antibacterial activity of water and acetone extracts ofthe roots of Euclea natalensis. J. Ethnopharmacol. 72, 313\u2013316. doi:10.1016/s0378-8741(00)00231-2Lall, N., Meyer, J., Wang, Y., Bapela, N., Rensburg, C., Fourie, B., et al. (2005a).Characterization of intracellular activity of antitubercular constituents from the roots ofEuclea natalensis. Pharm. Biol. 43 (4), 353\u2013357. doi:10.1080/13880200590951829Lall, N., Weiganand, O., Hussein, A., and Meyer, J. (2006). Antifungal activity ofnaphthoquinones and triterpenes isolated from the root bark of Euclea natalensis.Euclea natalensis S. Afr. J. Bot. 72, 579\u2013583. doi:10.1016/j.sajb.2006.03.005Long, C. (2005). Swaziland\u2019s flora: SiSwati names and uses. Swaziland National TrustCommission. [Last accessed on 2021 June 15] Available at: http://www.sntc.org.sz/index.asp.Maroyi, A. (2017). Euclea undulata thumb: Review of its botany, ethnomedicinal uses,phytochemistry and biological activities. Asian pac. J. Trop. Med., 1\u20137.Masoga, M. A. (2020). \u201cCritical reflections on selected local narratives of contextualSouth African indigenous knowledge,\u201d in African studies: Breakthroughs in Researchand practice (IGI Global), 295\u2013316.Mbanga, J., Ncube, M., and Magumura, A. (2013). Antimicrobial activity of Eucleaundulata, Euclea divinorum and Diospyros lycioides extracts on multi-drug resistantStreptococcus mutans. J. Med. Plant Res. 7 (37), 2741\u20132746.Mbaveng, A., and Kuete, V. (2014). Review of the chemistry and pharmacology of 7-Methyl jugulone. Afr. Health Sci. 14 (1), 201\u2013205. doi:10.4314/ahs.v14i1.31Mcgaw, L., Lall, N., Hlokwe, T., Michel, A., Meyer, J. M., and Eloff, J. (2008). Purifiedcompounds and extracts from Euclea species with antimycobacterial activity againstMycobacterium bovis and fast-growing Mycobacteria. Biol. Pharm. Bull. 31 (7),1429\u20131433. doi:10.1248/bpb.31.1429Mebe, P., Cordell, G., and Pezzuto, J. (1998). Pentacyclic triterpenes andnaphthoquinones from Euclea divinorum. Phytochemistry 47 (2), 311\u2013313. doi:10.1016/s0031-9422(97)00398-1Mekonnen, A., Atlabachew, M., Kassie, B., and Brien, J. A. E. (2018). Investigation ofantioxidant and antimicrobial activities of Euclea schimperi leaf extracts. Chem. Biol.Technol. Agric. 5 (1), 1\u201324. doi:10.1007/s40801-017-0125-6Moosavi, B., Liu, S., Wang, N., Zhu, X., and Yang, G. (2020). The anti-fungal \u03b2-sitosterol targets the yeast oxysterol-binding protein Osh4. Pest Manag. Sci. 76 (2),704\u2013711. doi:10.1002/ps.5568Morris, B., and Msonthi, J. D. (1996). Chewa medical botany: A study of herbalism insouthern Malawi, 2. LIT Verlag M\u00fcnster.Motlhanka, D. M. T., and Nthoiwa, G. P. (2013). Ethnobotanical survey of medicinalplants of tswapong north, in eastern Botswana: A case of plants from mosweu andseolwane villages. Eur. J. Med. Plants. 3 (1), 10\u201324. doi:10.9734/ejmp/2013/1871Frontiers in Pharmacology frontiersin.org16Taye et al. 10.3389/fphar.2023.1170145Mueller-harvey, I., Reed, J., and Hartley, R. (1987). Characterisation of phenoliccompounds, including flavonoids and tannins, of ten ethiopian browse species by highperformance liquid chromatography. J. Sci. Food Agri. 39, 1\u201314. doi:10.1002/jsfa.2740390102Mugomeri, E., Chatanga, P., Hlapisi, S., and RahaL (2014). Phytochemicalcharacterisation of selected herbal products in Lesotho. Lesotho Med. Assoc. J. 12(1), 38\u201347.Nanyingi, M. O., Mbaria, J. M., Lanyasunya, A. L., Wagate, C. G., Koros, K. B.,Kaburia, H. F., et al. (2008). Ethnopharmacological survey of Samburu district, Kenya.J. Ethnobiol. Ethnomed. 4 (1), 14\u201312. doi:10.1186/1746-4269-4-14Neuwinger, H. D. (2000). African traditional medicine: A dictionary of plant use andapplications. With supplement: Search system for diseases. Stuttgart, Germany:Medpharm. Scientific Publ., 213.Nordeng, H., and Havnen, G. C. (2005). Impact of socio-demographic factors,knowledge and attitude on the use of herbal drugs in pregnancy. Acta ObstetriciaGynecol. Scand. 84 (1), 26\u201333. doi:10.1111/j.0001-6349.2005.00648.xOmara, T., Kiprop, A. K., Ramkat, R. C., Cherutoi, J., Kagoya, S., Moraa Nyangena, D., et al.(2020). Medicinal plants used in traditional management of cancer in Uganda: A review ofethnobotanical surveys, phytochemistry, and anticancer studies. Evid. Based Complement.Altern. Med. 2020, 1\u201326. Article ID 3529081. doi:10.1155/2020/3529081Oosthuizen, C. B., and Lall, N. (2020). \u201cEuclea natalensis,\u201d in Underexploredmedicinal plants from sub-saharan Africa (Academic Press), 111\u2013116.Orzalesi, G., Mezzetti, T., Rossi, C., and Bellavita, V. (1970). Pentacyclic triterpenoidsfrom Euclea kellau. Planta Medica 19 (1), 30\u201336. doi:10.1055/s-0028-1099801Palanisamy, C., and Ashafa, T. (2018). Analysis of novel C-X-C chemokine receptortype 4 (CXCR4) inhibitors from hexane extract of Euclea crispa (Thunb.) leaves bychemical fingerprint identification and molecular docking analysis. J. Young Pharm. 10(2), 173\u2013177. doi:10.5530/jyp.2018.10.39Palanisamy, C., Cui, B., Zhang, H., Trung, N., Tran, H., Khanh, T., et al. (2020).Characterization of (2E,6E)-3,7,11trimethyldodecane-2,6,10-trien-1-ol withantioxidant and antimicrobial potentials from Euclea crispa (Thunb.) leaves. Int.Lett. Nat. Sci. 80, 51\u201363. doi:10.56431/p-v34u92Palanisamy, C., Selvarajan, R., Balogun, F., Kanakasabapathy, D., and Ashafa, A.(2019). Antioxidant and antimicrobial activities of (6E, 10E)-2, 6, 24-trimethylpentacosa-2, 6, 10-triene from Euclea crispa leaves. S. Afr. J. Bot. 124, 311\u2013319.doi:10.1016/j.sajb.2019.03.019Palmer, E., and Pitman, N. (1972). Trees of southern Africa: Covering all knownindigenous species in the republic of South Africa, south-west Africa, Botswana, Lesotho& Swaziland.volumes 1 & 2.Trees of southern Africa: Covering all known indigenousspecies in the Republic of South Africa, south-west Africa, Botswana, Lesotho &Swaziland. Volumes 1 & 2.Philip, K., Elizabeth, M., Cheaplogoi, P., Langat, M., and Hoseah, M. (2018). In vitroantiplasmodial and toxicity activities of crude extracts and compounds from Euclea latideus(Ebenaceae). Int. J. Biochem. Res. Rev. 21 (1), 1\u201322. doi:10.9734/ijbcrr/2018/39603Rademana, S., Anantharaju, P., Madhunapantulab, S., and Lalla, N. (2019). Theantiproliferative and antioxidant activity of four indigenous South African plants. Afr.J. Tradit. Complement. Altern. Med. 16 (1), 13\u201323. doi:10.21010/ajtcam.v16i1.2Schmidt, E., Lotter, M., and McCleland, W. (2002). Trees and shrubs of Mpumalangaand Kruger national park. Jacana Media.Shauli, M. (2023). Acute toxicity and 28-day oral administration of Euclea natalesisextract in Swiss albino mice. J. Med. Lab. Sci. Technol. S. Afr. 5 (1), 1\u201310.Shumba, L. (2018). Phytochemical composition and bacterial activity of Eucleadivinorum.Sobiecki, J. F. (2002). A preliminary inventory of plants used for psychoactivepurposes in southern African healing traditions. Trans. R. Soc. S. Afr. 57 (1-2),1\u201324. doi:10.1080/00359190209520523Sparg, S. G., Van Staden, J., and J\u00e4ger, A. K. (2000). Efficiency of traditionally usedSouth African plants against schistosomiasis. J. Ethnopharmacol. 73 (1-2), 209\u2013214.doi:10.1016/s0378-8741(00)00310-xStafford, G. I., Pedersen, M. E., van Staden, J., and J\u00e4ger, A. K. (2008). Review onplants with CNS-effects used in traditional South African medicine against mentaldiseases. J. Ethnopharmacol. 119 (3), 513\u2013537. doi:10.1016/j.jep.2008.08.010Steenkamp, V. (2003). Traditional herbal remedies used by South African women forgynaecological complaints. J. Ethnopharmacol. 86 (1), 97\u2013108. doi:10.1016/s0378-8741(03)00053-9Taylor, J. L., Elgorashi, E. E., Maes, A., Van Gorp, U., De Kimpe, N., Van Staden, J.,et al. (2003). Investigating the safety of plants used in South African traditionalmedicine: Testing for genotoxicity in the micronucleus and alkaline comet assays.Environ. Mol. Mutagen 42 (3), 144\u2013154. doi:10.1002/em.10184Tinevimbo, C. (2017). Inhibition of \u03b1-amylase by Euclea crispa flavonoids andphenolics: Implication for herbal management of Diabetes Mellitus.Tshikalange, T., Lall, N., Meyer, J., and Mahapatra, A. (2007). In vitro HIV-1 reversetranscriptase inhibitory activity of naphthoquinones and derivatives from Eucleanatalensis. S.Afr. J. Bot. 73 (2), 339. doi:10.1016/j.sajb.2007.02.200Van Wyk, B. E., and Gericke, N. (2000). People\u2019s plants: A guide to useful plants ofsouthern Africa. Briza publications.Weigenand, O., Hussein, A., Lall, N., and Meyer, J. (2004). Antibacterial activity ofnaphthoquinones and triterpenoids from Euclea natalensis root bark. J. Nat. Prod. 67(11), 1936\u20131938. doi:10.1021/np030465dWHO (2019). WHO Global report on traditional and complementary medicine 2019.Available at: https://www.who.int/news/item-the-who-global-report-on-traditional-and-complementary-medicine (accessed September, 2022).Woldemedhin, B., Nedi, T., Shibeshi, W., and Shiferaw, M. (2017). Evaluation of thediuretic activity of the aqueous and 80% methanol extracts of the root of Eucleadivinorum Hiern (Ebenaceae) in sprague dawley rats. J. Ethnopharmacol. 1, 114\u2013121.doi:10.1016/j.jep.2017.01.015Wube, A. A., Streit, B., Gibbons, S., Asres, K., and Bucar, F. (2005). In vitro 12 (S)-HETE inhibitory activities of naphthoquinones isolated from the root bark of Euclearacemosa ssp. schimperi. J. Ethnopharmacol. 102 (2), 191\u2013196. doi:10.1016/j.jep.2005.06.009Yuan, H., Ma, Q., Ye, L., and Piao, G. (2016). The traditional medicine and modernmedicine from natural products. Molecules 21 (5), 1\u201318. doi:10.3390/molecules21050559Frontiers in Pharmacology frontiersin.org17Taye et al. 10.3389/fphar.2023.1170145"}